药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzonatate
Dapagliflozin
Dapagliflozin may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Imipramine oxide
Imipramine oxide may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Iprindole
Iprindole may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Lofepramine
Lofepramine may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Melitracen
Melitracen may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Quinupramine
Quinupramine may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Dibenzepin
Dibenzepin may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Amitriptylinoxide
Amitriptylinoxide may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Opipramol
Opipramol may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Oxaprotiline
Oxaprotiline may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Dosulepin
Dosulepin may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Butriptyline
Butriptyline may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Dimetacrine
Dimetacrine may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Amineptine
Amineptine may decrease the hypoglycemic activities of Sunitinib.
Benzonatate
Incadronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Incadronic acid.
Benzonatate
Tiludronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Tiludronic acid.
Benzonatate
Etidronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Etidronic acid.
Benzonatate
Risedronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Risedronic acid.
Benzonatate
Epitizide
The therapeutic efficacy of Sunitinib can be decreased when used in combination with Epitizide.
Benzonatate
Cyclopenthiazide
The therapeutic efficacy of Sunitinib can be decreased when used in combination with Cyclopenthiazide.